Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

Characterization of Cannabinoid Withdrawal Using Pyruvate Dehydrogenase as a Marker of Inhibition of In Vivo Neuronal Activity

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Characterization of Cannabinoid Withdrawal Using Pyruvate Dehydrogenase as a Marker of Inhibition of In Vivo Neuronal Activity

Published Date

2023

Publisher

Type

Presentation

Abstract

Immediate early genes, such as c-fos, are used as molecular markers of neuronal activation; however, there are currently no available molecular markers of neuronal inhibition. Immunohistochemistry (IHC) is used to map activity in different brain regions in response to different stimuli, such as drug administration, exposure to anesthesia, or novel environments. Based on previous literature, we used phosphorylated pyruvate dehydrogenase (pPDH) as a potential marker of neural inhibition. This study used two female rats that were intravenously injected with either WIN 55,212-2 (WIN), a synthetic cannabinoid, or a vehicle solution via jugular catheters on a schedule with increasing doses for four days (0.2-0.8 mg/kg). On the fifth day, a final dose of 0.8 mg/kg of WIN or vehicle was administered. Then, four hours later, they were both injected intraperitoneally with 10 mg/kg of rimonabant, a selective antagonist/inverse agonist of the CB1 receptor, and were sacrificed 90 minutes after rimonabant administration. Using this model of precipitated withdrawal, pPDH immunohistochemistry was performed to detect possible neural inhibition in select brain regions. The regions of interest include various regions in the hippocampus and amygdaloid nucleus. There was a qualitative difference in expression between saline and WIN samples, and more samples would need to be analyzed to include cell counts. More development of this protocol needs to be done to result in more reliable and valid pPDH detection in conjunction with a bigger, more diverse sample size. Future directions should explore the validity and reliability of pPDH as a marker of neural inhibition as well as using c-fos alongside pPDH to investigate the bidirectional nature of neural activity.

Keywords

Description

Faculty advisor: Sade M. Spencer

Related to

Replaces

License

Series/Report Number

Funding information

This research was supported by the Undergraduate Research Opportunities Program (UROP).

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Sternitzky, Anna R.; Spencer, Sade M.. (2023). Characterization of Cannabinoid Withdrawal Using Pyruvate Dehydrogenase as a Marker of Inhibition of In Vivo Neuronal Activity. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/259123.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.